Soliris (eculizumab) is a brand-name drug prescribed for certain autoimmune conditions in adults and some children. A healthcare professional administers Soliris as an IV infusion. The dosage can ...
Alexion's Soliris (eculizumab) is a blockbuster, earning $2.5 billion in 2015 from treating two life-threatening and ultra-rare disorders: paroxysmal nocturnal haemoglobinuria (PNH) and atypical ...
Alexion’s rare disease drug Soliris has a new indication after the FDA approved it for a disease that attacks the optic nerves. Approval of Soliris (eculizumab) for neuromyelitis optica spectrum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback